Skip to main content
. 2023 Jun 14;18(6):e0286303. doi: 10.1371/journal.pone.0286303

Fig 3. Proportion of CALHIV on MMD among those currently on ART at 36 SIDHAS-supported sites, by ARV supply and age group (October–December 2019 vs. January–March 2021).

Fig 3